Tammy McIver

Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)

Maryam Oskoui, John Day, Nicolas Deconinck et al. · Journal of Neurology · 2023 · 85 citations · Full text

Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler

Anna Bodzenta­‐Łukaszyk, Grażyna Pulka, Andrzej Dymek et al. · Respiratory Medicine · 2011 · 63 citations · Full text

Asthma, Single Pressurized, Allergy +6

Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment

Eugenio Mercuri, Giovanni Baranello, Odile Boespflug‐Tanguy et al. · European Journal of Neurology · 2022 · 59 citations · Full text

Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial

Anna Bodzenta­‐Łukaszyk, Jan van Noord, W Schröder-Babo et al. · Current Medical Research and Opinion · 2013 · 38 citations

Onset of Bronchodilation with Fluticasone/Formoterol Combination Versus Fluticasone/Salmeterol in an Open-Label, Randomized Study

René Aalbers, Guy Brusselle, Tammy McIver et al. · Advances in Therapy · 2012 · 32 citations · Full text